Nielsen Kirk G. 4
4 · SpyGlass Pharma, Inc. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
SpyGlass (SGP) 10% Owner Kirk G. Nielsen Receives 27,400-Share Award
What Happened
Kirk G. Nielsen, a reported 10% owner of SpyGlass Pharma, was granted 27,400 derivative shares (award code A) on February 5, 2026 at an acquisition price of $0.00. The award is subject to vesting and is reported as a derivative grant rather than an open-market purchase or sale.
Key Details
- Transaction date: February 5, 2026; Form 4 filed February 9, 2026. Filing does not indicate delinquency.
- Grant: 27,400 derivative shares reported at $0.00 per share.
- Shares owned after transaction: Not specified in this filing.
- Vesting footnote: Shares vest 1/36th each month following the grant date (Date of Grant = Feb 5, 2026), contingent on Nielsen continuing as an Outside Director under the issuer’s 2026 Equity Incentive Plan.
- Transaction type: Award/Grant of a derivative security (code A).
Context
This was a grant of a derivative award (likely restricted shares or units subject to vesting), not a sale or open-market purchase. As a 10% owner and Outside Director, Nielsen’s award is tied to continued service and vests monthly over three years, so the grant does not reflect an immediate change in market holdings or a cash transaction.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-02-05+27,400→ 27,400 totalExercise: $16.00Exp: 2036-02-05→ Common Stock (27,400 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2026 Equity Incentive Plan) through such applicable vesting date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Date of Grant on the same day of the month as the Date of Grant (and if there is no corresponding day, on the last day of the month). "Date of Grant" shall mean February 5, 2026.